MedPath

Prospective randomised clinical trial assessing the subsidence and rotation of two modular cementless femoral stems

Not Applicable
Conditions
End-stage Hip Osteoarthritis
Surgery - Other surgery
Musculoskeletal - Osteoarthritis
Registration Number
ACTRN12609001019291
Lead Sponsor
Global Orthopaedic Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
260
Inclusion Criteria

Inclusion Criteria
1.The individual has signed a Patient Informed Consent, specific to this study, and approved by the Institutional Ethics Review Board.
2.The individual is between the ages of 21 and 75 years.
3.The individual clinically qualifies for total hip arthroplasty (THA) surgery based on physical examination and history.
4.The individual is diagnosed with a primary diagnosis of Non Inflammatory Degenerative Joint Disease (osteoarthritis, traumatic arthritis, avascular necrosis, slipped capital epiphysis, pelvic fracture, femoral fracture, failed fracture fixation or diastrophic variant).
5.The individual is physically and mentally willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation (i.e., not currently being treated for a psychiatric disorder, senile dementia, Alzheimer’s disease, presence of alcohol/substance abuse).
6.The individual is skeletally mature.

Exclusion Criteria

Exclusion Criteria
1.The individual is classified as morbidly obese (>40 Body Mass Index).
2.The individual has an active infection within the affected hip joint.
3.The individual has a diagnosed systemic disease that would affect the subject’s welfare or overall outcome of the study (i.e., moderate to severe osteoporosis, Paget's disease, renal osteodystrophy), is immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
4.The individual is pregnant.
5.The individual is a prisoner.
6.The individual has plans to relocate to another geographic area before study completion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath